Scott Lindhorst

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency

Éric Bouffet, Valérie Larouche, Brittany Campbell et al. · Journal of Clinical Oncology · 2016 · 869 citations

Medicine, Molecular Genetics, Oncology +17

Comprehensive Analysis of Hypermutation in Human Cancer

Brittany Campbell, Nicholas Light, David Fabrizio et al. · Cell · 2017 · 796 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

Medicine, Immunology, Oncology +17

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 405 citations · Full text

Medicine, Immunology, Oncology +17

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

Christina Tsien, Stephanie L. Pugh, Adam P. Dicker et al. · Journal of Clinical Oncology · 2022 · 199 citations · Full text

Medicine, Oncology, Radiation Oncology +16